New risk scores predict early recurrence in liver cancer patients

Online preoperative and postoperative risk scores have been developed and validated for predicting early recurrence in patients with hepatocellular carcinoma (HCC) undergoing conversion liver resection after treatment with tyrosine kinase inhibitors and immune checkpoint inhibitors. The preoperative model identified key factors, achieving a c-index of 0.681, while the postoperative model scored 0.706. Both models demonstrate significant predictive accuracy and can assist clinicians in making informed surgical decisions and optimizing postoperative care for affected patients.